Paratek Pharmaceuticals to Present at Wedbush PacGrow Healthcare Conference 2021
BOSTON, Aug. 03, 2021 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel life-saving therapies for life-threatening diseases or other public health threats for civilian, government andmilitary use, today announced that Adam Woodrow, President and Chief Commercial Officer, will participate in a panel discussion at the Wedbush PacGrow Healthcare Conference 2021.
- BOSTON, Aug. 03, 2021 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel life-saving therapies for life-threatening diseases or other public health threats for civilian, government andmilitary use, today announced that Adam Woodrow, President and Chief Commercial Officer, will participate in a panel discussion at the Wedbush PacGrow Healthcare Conference 2021.
- The discussion will take place on August 11, 2021 at 4:40 p.m. E.T.
- Paratek Pharmaceuticals, Inc.is a commercial-stage biopharmaceutical company focused on the development and commercialization of novel life-saving therapies for life-threatening diseases or other public health threats for civilian, government andmilitary use.
- Paratek has a collaboration agreement withZaiLab for the development and commercialization of omadacycline in the greaterChinaregion and retains all remaining global rights.